Candoo Pharmatech Company Inc. is a technology-driven, customer-centric pharmaceutical CDMO specializing in advanced formulation and manufacturing solutions to small and large molecules. Candoo believes an innovative, efficient and affordable drug delivery platform is pivotal to substantially reduce the cost of new drug access. We provide experienced, agile and cost-effective contract development and manufacturing services including pre-formulation, formulation, analytical, dissolution, manufacturing, regulatory submission, GastroPlus modeling and IVIVC, and toxicology evaluation for global pharmaceutical and biotech industries. We have proven track record of success to develop first-to-file products (Paragraph IV), achieve target drug absorption profile, pass bioequivalence studies right-first-time, and get FDA regulatory approval within one review cycle. Our expertise spans a broad spectrum of oral, topical and parenteral dosage forms in the fields of NDA, 505b(2) and generics (ANDA). We effectively support pharma, biotech and medical research institutions all over the world accelerate molecules to medicines with PBPK model-informed developability assessment, best fit formulation, scalable manufacturing process and faster turnaround time. Candoo was founded in 2018 and is a Canadian subsidiary of Crystal Pharmatech. As a member of Ontario Research Innovation & Commercialization Center, industrial partner of Canada Natural Sciences and Engineering Research Council (NSERC) CREATE Training Program for Controlled Release Leaders (ContRoL) and Mitacs Research and Development Program, Candoo has the state-of-the-art R&D and cGMP facilities of 12,500 square feet (cGMP facility under renovation), equipped with modern and cGMP-compliance equipment, and locates at the pharmaceutical business park in Mississauga, Ontario, the hub of pharmaceutical industry in Canada.
External link for Candoo Pharmatech Company Inc.
Mississauga, Ontario L5N 5M1, CA
Candoo Pharmatech Company Inc. reposted this
Founder & CEO at Candoo Pharmatech Company Inc.; Adjunct Lecturer at University of Toronto
Candoo CDMO is hiring for business development / subject matter expert roles! If you are looking for positions where you can create positive impact and accelerate new drug development, welcome to send your resume to hr@candoopharmatech.com. Together, #WeCandooIt!
Candoo Pharmatech Company Inc. reposted this
Founder & CEO at Candoo Pharmatech Company Inc.; Adjunct Lecturer at University of Toronto
There is no such thing as second place - either you’re first or you lose. It doesn’t matter if your molecule is not the first compound in the category, you can still be the first to be approved by the FDA. We developed a complex first-to-file product that obtained FDA approval within ONE review cycle. And we can help you do the same! Get it right the first time, on time. Email bd@candoopharmatech.com to learn more about how we can accelerate your molecule to market first in line! Together, #WeCandooIt!
Candoo Pharmatech Company Inc. reposted this
Founder & CEO at Candoo Pharmatech Company Inc.; Adjunct Lecturer at University of Toronto
Each molecule is unique, so is your dissolution method. A generalized dissolution method lack of discriminatory power will delay the regulatory approval of your clinical trials and new drug application (NDA). Candoo CDMO dissolution specialists have rich experiences in QbD-based dissolution method development, and obtained FDA approval within one review cycle. Send your request to bd@candoopharmatech.com to schedule a free consultation. Together, #WeCandooIt!
Candoo Pharmatech Company Inc. reposted this
Founder & CEO at Candoo Pharmatech Company Inc.; Adjunct Lecturer at University of Toronto
We are hiring! We are looking for motivated business development talents/subject matter experts to join our team and extend Candoo CDMO services to prospective partners to accelerate molecules to market. Visit https://lnkd.in/gntQyY_K for details. Send your resume to hr@candoopharmatech.com. Together, #WeCandooIt!
Candoo Pharmatech Company Inc. reposted this
Founder & CEO at Candoo Pharmatech Company Inc.; Adjunct Lecturer at University of Toronto
Dreading making the 10,000 mile trip to go visit your molecule? Wish you can quickly pop in and have a face-to-face at a CDMO in less than a day? With Candoo’s CDMO, you can! We’re your trusted CDMO right next door, so you can check in on your precious molecule without sacrificing your time, budget, or resources. Email bd@candoopharmatech.com to see what Candoo can do for you! Together, #WeCandooIt!
Candoo Pharmatech Company Inc. reposted this
Founder & CEO at Candoo Pharmatech Company Inc.; Adjunct Lecturer at University of Toronto
Your molecule is unique and your time is precious. So don't waste either using a general approach. As formulation specialist, Candoo CDMO personalizes each formulation strategy to your molecule to accelerate your molecule to market. We've advanced many new compounds to clinical and early commercializaion stages, and obtained FDA approval within one review cycle. Best part? We're right next door in Toronto, Canada. Send an email now to bd@candoopharmatech.com to receive a free 30-minute consultation to see how we can help you. Together, #WeCandooIt!
Candoo Pharmatech Company Inc. reposted this
Founder & CEO at Candoo Pharmatech Company Inc.; Adjunct Lecturer at University of Toronto
Tired of waiting for your shipment to clear customs? Why not try a CDMO next door? Candoo’s new cGMP CDMO facility for clinical supply is coming soon. Stay tuned! Together, #WeCandooIt!
Candoo Pharmatech Company Inc. reposted this
Founder & CEO at Candoo Pharmatech Company Inc.; Adjunct Lecturer at University of Toronto
Each molecule is unique, so why use the same formulation for them all? A general formulation strategy that isn’t tailored to your molecule may lead to low drug exposure and high inter-subject variability even if the molecule has good permeability. By developing custom formulations, Candoo has advanced many new molecules to clinical and early commercialization stages. Send your request to bd@candoopharmatech.com to schedule a free 30-minute consultation and let our experts create the right fit for your molecule. Together, #WeCandooIt!
Candoo Pharmatech Company Inc. reposted this
Founder & CEO at Candoo Pharmatech Company Inc.; Adjunct Lecturer at University of Toronto
Worried by the poor absorption of your precious molecule? We can help! Candoo’s tailored formulation strategy can save your molecule and save your time. Our formulation experts have advanced many new molecules to clinical and early commercialization stages. For a limited time only, we’re offering a free 30-minute consultation. Send your request to bd@candoopharmatech.com. Together, #WeCandooIt!
Candoo Pharmatech Company Inc. reposted this
Founder & CEO at Candoo Pharmatech Company Inc.; Adjunct Lecturer at University of Toronto
Each molecule is unique. A wrong formulation strategy will not just delay product development timeline, but also waste your precious molecule. Candoo formulation experts have advanced many new molecules to clinical and early commercialization stages, and obtained FDA approval for first-to-file complex drug product within one review cycle. For a limited time only, we offer a 30-minute free consultation to discuss formulation challenges you are facing. Send your request to bd@candoopharmatech.com. Together, #WeCandooIt!